Atlas of Genetics and Cytogenetics in Oncology and Haematology


Home   Genes   Leukemias   Solid Tumors   Cancer-Prone   Deep Insight   Case reports   Journals   Portal   Teaching   

X Y 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 NA

 

Recent papers

    ( Database Archives )

Table of Content

2017_06 Genes ALCAM (Activated Leukocyte Cell Adhesion Molecule)
2017_06 Deep Insights LINE-1-encoded Reverse Transcriptase in the genesis and therapy of cancer
2017_06 Leukaemias t(18;21)(p11;q11)
2017_06 Leukaemias i(8)(q10) in ALL
2017_06 Leukaemias del(7)(p11-15) solely
2017_06 Leukaemias Myelodysplastic syndrome with excess blasts
2017_06 Leukaemias Acute lymphoblastic leukemia in Down syndrome
2017_06 Leukaemias Florid follicular hyperplasia PTLD
2017_06 Case Reports Isolated 1q21 rearrangement der(20)t(1;20)(q21;p13) with telomere involvement of 20p in a case of longstanding myelodysplastic syndrome
2017_05 Genes C2orf3
2017_05 Leukaemias t(1;8)(p21-22;q24)
2017_05 Leukaemias dup(1q) in ALL
2017_05 Leukaemias del(1p) solely
2017_05 Leukaemias Mixed phenotype acute leukemia (MPAL)
2017_05 Leukaemias Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)
2017_04 Solid Tumors Kidney: Renal Oncocytoma
2017_04 Leukaemias M3/M3v acute myeloid leukemia (AML M3/M3v)
2017_04 Leukaemias Castleman's disease
2017_04 Genes WDR48 (WD repeat domain 48)
2017_04 Genes PIP5K1A (phosphatidylinositol-4-phosphate 5-kinase type 1 alpha)
2017_04 Genes INPP4B (Inositol Polyphosphate-4-Phosphate Type II B)
2017_04 Leukaemias t(6;11)(q24.1;p15.5) NUP98/CCDC28A
2017_04 Leukaemias t(4;9)(q21.22;p24) SEC31A/JAK2
2017_04 Leukaemias t(1;8)(p11-13;q24)
2017_04 Leukaemias t(1;5)(p32;q31) without TAL1 rearrangement
2017_04 Leukaemias Polymorphic PTLD
2017_04 Leukaemias Myeloid/Lymphoid neoplasms with abnormalities of PDGFRB
2017_04 Leukaemias Myeloid/Lymphoid neoplasms with abnormalities of PDGFRA
2017_04 Leukaemias Monomorphic PTLD (B- and T/NK-cell types)
2017_04 Leukaemias Double Hit Lymphoma (DHL)
2017_04 Leukaemias Classical Hodgkin lymphoma type PTLD
2017_03 Solid Tumors Soft Tissues: Extraskeletal myxoid chondrosarcoma
2017_03 Genes MAPK6 (mitogen-activated protein kinase 6)
2017_03 Genes MAPK4 (mitogen-activated protein kinase 4)
2017_03 Genes CEBPE (CCAAT/enhancer binding protein epsilon)
2017_03 Leukaemias t(14;19)(q32;p13) IGH/EPOR
2017_03 Leukaemias t(11;11)(q14;q23) KMT2A/PICALM
2017_03 Leukaemias t(X;11)(q28;p15) NUP98/HMGB3
2017_03 Leukaemias t(5;11)(q33;q13) NUMA1/PDGFRB a novel fusion
2017_03 Leukaemias t(3;17)(q26;q12-21) TBL1XR1/RARA
2017_03 Leukaemias t(2;17)(q32;q21) NABP1/RARA
2017_03 Leukaemias t(1;17)(p34;q21) IRF2BP2/RARA
2017_03 Leukaemias del(X)(p22p22) P2RY8/CRLF2
2017_03 Leukaemias Myeloid proliferations in Down syndrome
2017_02 Leukaemias t(4;11)(q21;q23) KMT2A/AFF1
2017_02 Solid Tumors Kidney: ALK-rearranged renal cell carcinoma
2017_02 Genes WNT10B (wingless-type MMTV integration site family)
2017_02 Genes PGR (progesterone receptor)
2017_02 Leukaemias t(17;20)(q21;q11)
2017_02 Leukaemias r(8)
2017_02 Leukaemias inv(11)(p15q23) NUP98/KMT2A
2017_02 Leukaemias i(X)(q10) in male patients
2017_02 Leukaemias i(Xq10) in female patients
2017_02 Leukaemias del(18)(p11)
2017_02 Leukaemias Early T-cell precursor acute lymphoblastic leukemia
2017_01 Leukaemias t(5;17)(q35;q21) NPM1/RARA
2017_01 Leukaemias dic(9;12)(p13;p13) PAX5/ETV6
2017_01 Genes PIMREG (PICALM interacting mitotic regulator)
2017_01 Leukaemias t(5;17)(p11;q11)
2017_01 Leukaemias i(7)(q10)
2017_01 Leukaemias del(6q)
2017_01 Leukaemias Multiple Myeloma
2017_01 Leukaemias Aggressive natural killer leukemia (ANKL)
2017_01 Leukaemias Acute myeloid leukemia with myelodysplasia related changes
2016_12 Solid Tumors t(2;2)(p22;p22) LTBP1/BIRC6
2016_12 Solid Tumors Male breast cancer
2016_12 Genes SPARC (secreted protein acidic and cysteine-rich)
2016_12 Genes MIR150
2016_12 Genes ARHGAP21 (Rho GTPase activating protein 21)
2016_12 Leukaemias t(7;11)(p15;p15) NUP98/HOXA13
2016_12 Leukaemias t(5;17)(q35;q21) without RARA involvement in non-M3 AML
2016_12 Leukaemias t(5;14)(q35;q11) RANBP17 (or TLX3)/TRD
2016_12 Leukaemias t(2;2)(p22;p22) LTBP1/BIRC6
2016_12 Leukaemias i(X)(p10) in male patients
2016_12 Leukaemias i(X)(p10) in female patients
2016_12 Leukaemias dic(5;17)(q11-14;p11-13)
2016_12 Leukaemias Classification of Hodgkin lymphoma over years
2016_11 Solid Tumors Bone: Vascular Tumors
2016_11 Solid Tumors Kidney: Papillary adenoma
2016_11 Solid Tumors Kidney: Metanephric adenoma
2016_11 Solid Tumors Kidney: Chromophobe renal cell carcinoma
2016_11 Solid Tumors Bone: Angiosarcoma
2016_11 Genes HLTF (helicase-like transcription factor)
2016_11 Genes PTPN9 (protein tyrosine phosphatase, non-receptor type 9)
2016_11 Leukaemias t(X;10)(p11;p12) DDX3X/MLLT10
2016_11 Leukaemias t(6;9)(p22;q34) DEK/NUP214 in Childhood
2016_11 Leukaemias i(18)(q10)
2016_11 Leukaemias dup (11q) in myeloid malignancies
2016_11 Leukaemias Mediastinal Gray Zone Lymphoma
2016_11 Leukaemias Follicular Dendritic Cell Sarcoma
2016_10 Cancer Prone Diseases Ataxia telangiectasia (A-T)
2016_10 Genes ATM (ataxia telangiectasia mutated)
2016_10 Genes KNL1 (cancer susceptibility candidate 5)
2016_10 Genes GSKIP (GSK3-beta interaction protein)
2016_10 Genes FMNL1 (formin like 1)
2016_10 Genes ATG2B (Autophagy-related 2B)
2016_10 Leukaemias del (5q) solely in Myelodysplastic syndrome
2016_10 Leukaemias del(13q) in chronic lymphocytic leukemia
2016_10 Leukaemias del(5)(q32q33) EBF1/PDGFRB
2016_10 Leukaemias Myelodysplastic/myeloproliferative neoplasm with ring sideroblasts and thrombocytosis (MDS/MPN-RS-T)
2016_09 Leukaemias t(1;9)(q24;q34) RCSD1/ABL1
2016_09 Leukaemias t(1;3)(p36;q21) PSMD2/PRDM16 ???
2016_09 Solid Tumors Nervous system: Astrocytoma with t(1;17)(p36;q21) SPOP/PRDM16
2016_09 Solid Tumors Breast: carcinoma with t(1;3)(p36;q13) PRDM16/BBX
2016_09 Genes KLK9 (kallikrein-related peptidase 9)
2016_09 Genes KLK14 (kallikrein-related peptidase 14
2016_09 Genes KLK13 (kallikrein-related peptidase 13)
2016_09 Genes KLK12 (kallikrein-related peptidase 12)
2016_09 Leukaemias der(X)t(X;8)(q28;q11.2)
2016_09 Leukaemias t(3;9)(p13;q34.1) FOXP1/ABL1
2016_09 Leukaemias t(1;22)(p36;q11) IGL/PRDM16
2016_09 Leukaemias t(1;17)(p36;q21) WNT3 or NSF/PRDM16
2016_09 Leukaemias t(1;3)(p36;q21) RPN1/PRDM16
2016_09 Leukaemias t(1;1)(p36;p36) PRDM16/SKI
2016_09 Leukaemias del(9p) in Acute Lymphoblastic Leukemia
2016_09 Leukaemias Primary mediastinal B-cell lymphoma (PMBL)
2016_08 Solid Tumors Kidney: Renal cell carcinoma with t(X;1)(p11;p34) SFPQ/TFE3
2016_08 Solid Tumors Kidney: Renal cell carcinoma with t(X;1)(p11;q21) PRCC/TFE3
2016_08 Solid Tumors Kidney: Renal cell carcinoma with inv(X)(p11q12) NONO/TFE3
2016_08 Solid Tumors Kidney: Renal cell carcinoma with t(X;17)(p11;q23) CLTC/TFE3
2016_08 Solid Tumors Kidney: Renal cell carcinoma with t(6;11)(p21;q12) MALAT1/TFEB
2016_08 Solid Tumors Kidney: Renal cell carcinoma with t(X;17)(p11;q25) ASPSCR1/TFE3
2016_08 Leukaemias t(7;12)(q36;p13) MNX1/ETV6
2016_08 Leukaemias t(2;11)(p21;q23) KMT2A/?
2016_08 Solid Tumors Kidney: Renal cell carcinomas with MiT family translocation
2016_08 Genes PDCD10 (Programmed cell death 10)
2016_08 Genes DOT1L (DOT1 like histone H3K79 methyltransferase)
2016_08 Genes CALR (calreticulin)
2016_08 Leukaemias t(2;11)(p21;q23) without KMT2A (MLL) rearrangement
2016_08 Leukaemias t(1;12)(p36;p13) ETV6/PRDM16
2016_08 Leukaemias t(1;7)(p36;p12) IKZF1/PRDM16
2016_08 Leukaemias T-cell/histiocyte rich large B-cell lymphoma
2016_08 Leukaemias In situ follicular neoplasia
2016_08 Case Reports Ring Chromosome 8 as a sole abnormality: An adverse prognostic indicator in Acute Myeloid Leukemia?
2016_07 Leukaemias t(1;2)(p36;p21) THADA/PRDM16
2016_07 Leukaemias t(3;21)(q26;q11) NRIP1/MECOM
2016_07 Leukaemias t(3;7)(q26;q21) CDK6/MECOM
2016_07 Leukaemias t(1;1)(p36;q41) DUSP10/PRDM16
2016_07 Leukaemias inv(3)(p24q26) ?/MECOM
2016_07 Case Reports A new case of acute lymphoblastic leukemia with der(X)t(X;8)(q28;q11.2)
2016_06 Genes HNF4A (Hepatocyte Nuclear Factor 4 alpha)
2016_06 Genes CFAP99 (Cilia and Flagella Associated Protein 99)
2016_06 Leukaemias der(1)t(1;1)(p36;q11-q32) in hematopoietic malignancies
2016_06 Leukaemias i(4p) in myeloid malignancies
2016_06 Leukaemias dup(1)(q11-q44) in myeloid malignancies
2016_06 Leukaemias Nodular sclerosis classical Hodgkin lymphoma (NScHL)
2016_06 Leukaemias Mu heavy chain disease
2016_06 Leukaemias Mixed cellularity classical Hodgkin lymphoma (MCcHL)
2016_06 Leukaemias B-cell lymphoma, unclassifiable, with features intermediate between diffuse large B-cell lymphoma and classical Hodgkin lymphoma
2016_06 Leukaemias Infectious mononucleosis-like PTLD
2016_06 Leukaemias Gamma heavy chain disease
2016_06 Leukaemias Alpha heavy chain disease
2016_06 Case Reports Amplification of the MET/7q31 gene in a patient with myelodysplastic syndrome
2016_05 Leukaemias t(8;21)(q22;q22) RUNX1/RUNX1T1
2016_05 Leukaemias t(8;14)(q24;q32) IGH/MYC
2016_05 Genes IRS2 (insulin receptor substrate 2)
2016_05 Leukaemias Plasmablastic lymphoma (PBL)
2016_05 Leukaemias Pediatric-type Follicular Lymphoma
2016_05 Leukaemias HIV-associated lymphomas
2016_05 Leukaemias Anaplastic large cell lymphoma, ALK-negative
2016_05 Case Reports t(14;20)(q11.2;q13.3) involving the T-cell receptor α/δ gene in a pediatric acute lymphoblastic leukemia B-cell type
2016_05 Case Reports A new case of adult Acute Myeloid Leukemia with isolated tetrasomy 4p
2016_04 Cancer Prone Diseases Fanconi anemia
2016_04 Genes TP53 (Tumour protein p53 (Li-Fraumeni syndrome))
2016_04 Leukaemias t(7;21)(p22;q22) RUNX1/USP42
2016_04 Genes TYRP1 (tyrosinase-related protein 1)
2016_04 Genes SLC24A5 (solute carrier family 24 (sodium/potassium/calcium exchanger), member 5)
2016_04 Genes RHOBTB3 (Rho-related BTB domain containing 3)
2016_04 Genes PARK7 (Parkinsonism associated deglycase)
2016_04 Genes OCA2 (OCA2 melanosomal transmembrane protein)
2016_04 Genes HMGN5 (High Mobility Group Nucleosome binding domain 5)
2016_04 Genes DAPK2 (death-associated protein kinase 2)
2016_04 Genes LMDRA (leucine rich melanocyte differentiation associated)
2016_04 Deep Insights Internet databases and resources for cytogenetics and cytogenomics
2016_04 Deep Insights General resources in Genetics and/or Oncology
2016_04 Deep Insights Cancer Cytogenomics resources
2016_04 Leukaemias Nodular lymphocyte-predominant Hodgkin lymphoma
2016_04 Leukaemias Lymphocyte depletion classical Hodgkin lymphoma
2016_04 Leukaemias Lymphocyte-rich classical Hodgkin lymphoma
2016_04 Leukaemias Classical Hodgkin lymphoma
2016_03 Genes SYK (spleen tyrosine kinase)
2016_03 Leukaemias t(15;17)(q24;q21) PML/RARA
2016_03 Leukaemias t(9;11)(p21;q23) KMT2A/MLLT3
2016_03 Genes PPP2R1A (protein phosphatase 2 regulatory subunit A, alpha)
2016_03 Leukaemias t(X;14)(q28;q11.2) TRA-TRD/MTCP1
2016_03 Leukaemias Disseminated Juvenile Xanthogranuloma
2016_02 Genes RHOBTB2 (Rho-related BTB domain containing 2)
2016_02 Genes RHOBTB1 (Rho-related BTB domain containing 1)
2016_02 Genes RACGAP1 (Rac GTPase activating protein 1)
2016_02 Genes RAB31 (Ras-related protein in brain 31)
2016_02 Leukaemias der(5)t(1;5)(q12-q25;q13-q35)
2016_01 Genes PAWR (PRKC apoptosis WT1 regulator protein; Prostate apoptosis response-4, Par-4)
2016_01 Leukaemias t(4;11)(q23;p15) NUP98/RAP1GDS1
2016_01 Genes EEF2K (eukaryotic elongation factor 2 kinase)
2016_01 Leukaemias der(9)t(1;9)(q12;q12)
2016_01 Leukaemias der(1;9)(q10;p10)
2015_12 Cancer Prone Diseases Mulibrey nanism
2015_12 Cancer Prone Diseases Denys-Drash syndrome (DDS)
2015_12 Genes PRKN (arkin RBR E3 ubiquitin protein ligase )
2015_12 Genes NGFR (nerve growth factor receptor)
2015_12 Genes GLS2 (Glutaminase 2)
2015_12 Genes DND1 (DND microRNA-mediated repression inhibitor 1)
2015_12 Genes DHFR (dihydrofolate reductase)
2015_12 Leukaemias t(11;17)(p15;q21) NUP98/?
2015_12 Leukaemias t(7;15)(q22;q14) CUX1/NUTM1 a novel fusion
2015_12 Leukaemias t(2;9)(q12;q34) RANBP2/ABL1
2015_12 Leukaemias der(11)t(1;11)(q11-23;q14-25)
2015_12 Leukaemias der(9)t(1;9)(q11-12;q34)
2015_12 Case Reports T-cell acute lymphoblastic leukemia with t(4;11)(q23;p15) and NUP98/RAP1GDS1 gene fusion: Case report and review of literature
2015_12 Case Reports A pediatric case of acute lymphoblastic leukemia with t(2;9)(q12;q34) (RANBP2/ABL1 fusion)
2015_11 Cancer Prone Diseases Peutz-Jeghers syndrome
2015_11 Genes KIT (v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog)
2015_11 Genes GATA2 (GATA binding protein 2)
2015_11 Leukaemias der(1;7)(q10;p10)
2015_11 Genes NDUFA13 (NADH:ubiquinone oxidoreductase subunit A13)
2015_11 Genes CYB5A (Cytochrome B5 Type A (microsomal))
2015_11 Leukaemias Unbalanced whole-arm translocation der(1;10)(q10-q11;p10-p12)
2015_10 Genes NDRG1 (N-myc downstream regulated 1)
2015_10 Genes HMGA2 (high mobility group AT-hook 2)
2015_10 Genes KDR (kinase insert domain receptor)/Vascular Endothelial Growth Factor Receptor 2 (VEGFR2)
2015_09 Cancer Prone Diseases Familial Myeloproliferative Disorders
2015_09 Genes ZAP70 (zeta-chain (TCR) associated protein kinase 70kDa)
2015_09 Genes PIP4K2A (phosphatidylinositol-5-phosphate 4-kinase, type II, alpha)
2015_09 Leukaemias der(12)t(1;12)(q11-21;p11-13)
2015_09 Case Reports An adult case of biphenotypic acute leukemia with t(6;14)(q25;q32)


© Atlas of Genetics and Cytogenetics in Oncology and Haematology
indexed on : Mon Aug 14 13:47:09 CEST 2017

Home   Genes   Leukemias   Solid Tumors   Cancer-Prone   Deep Insight   Case reports   Journals   Portal   Teaching   

X Y 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 NA